New Chief Residents for 2021-22
Please join me in welcoming Dr. Monica Abdelmalak and Dr. Gina Sotolongo, who will serve as Chief Residents for the 2021-22 academic year!
Match Day - Announcing our New Residents for 2021
We are delighted to announce the incoming AP/CP Pathology Residents for 2021!
Huang Lab Discovers Prostate Cancer Mechanism
Huang lab discovers novel metabolic mechanism responsible for therapy resistance and disease progression of prostate cancer
Hale Named Distinguished Nominee for Hammes Teaching Award
A committee of biomedical graduate students has selected Professor of Pathology Laura Hale, MD PhD, as a distinguished nominee for the 2021 Gordon G. Hammes Faculty Teaching Award.
Judy Zhu Urologic Cancer Research Fund Established
Ms. Judy Zhu, a Canadian Citizen and an entrepreneur, has established the Judy Zhu Urologic Cancer Research Fund in the Department of Pathology and DCI Center for Prostate & Urologic Cancers to support the research conducted in Dr. Jiaoti Huang’s laboratory.
New Roles for Cummings with AAOOP and USCAP
Thomas J. Cummings, MD, Professor of Pathology and Ophthalmology, Division Chief of Neuropathology, and Residency Program Director, has been elected by the American Association of Ophthalmic Oncologists and Pathologists (AAOOP) to serve as Committee Representative to the United States and Canadian Academy of Pathology (USCAP)
Former Trainee Procop Receives Honors
Gary Procop MD MS, a former trainee in the Duke Department of Pathology (Resident in Anatomic and Clinical Pathology, 1992-6; Chief Resident, 1995-6) has recently won two major accolades.
Jessica Waibl Polania Awarded Ghaffari Fellowship
Jessica Waibl Polania, third year doctoral student in the Pathology PhD Program, was awarded the Paul and Lauren Ghaffari Graduate Fellowship from the Duke Graduate School.
Vaccine Strategy for UTIs from Abraham Lab
Goodbye UTIs: Duke scientists develop vaccine strategy for urinary tract infections
López Receives 3-Year KL2 Award
Giselle López, MD PhD is one of three recipients of the Duke Clinical and Translational Science Institute KL2 Award, which will allow her to pursue studies on hypercellular nodules in the oligodendroglioma tumor microenvironment, and their impact on prognosis.